Yuko Kitagawa
- Gastroenterology top 2%
-
- Gastric Cancer Management and Outcomes 4
- Gallbladder and Bile Duct Disorders 2
-
- Esophageal Cancer Research and Treatment 3
- Esophageal and GI Pathology 2
-
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Surgical Treatments 3
- COVID-19 and healthcare impacts 3
-
- Neuroendocrine Tumor Research Advances 3
Yuko Kitagawa
4 papers receiving 310 citations
Hit Papers
Peers
Comparison fields: 5 of 25
- Gastroenterology 287
- Pulmonary and Respiratory Medicine 248
- Surgery 196
- Neurology 25
- Rheumatology 16
Countries citing papers authored by Yuko Kitagawa
This map shows the geographic impact of Yuko Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Kitagawa more than expected).
Fields of papers citing papers by Yuko Kitagawa
This network shows the impact of papers produced by Yuko Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Kitagawa. The network helps show where Yuko Kitagawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuko Kitagawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 0 | |
| 12 | 2024 | 0 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 0 | |
| 15 | The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelinesbreakdown → | 2015 | 310 |
About Yuko Kitagawa
Yuko Kitagawa is a scholar working on Oncology, Hepatology and Physiology, having authored 15 papers that have together received 315 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Esophageal Cancer Research and Treatment (3 papers), COVID-19 and healthcare impacts (3 papers), Esophageal and GI Pathology (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Gastroenterology (287 citations), Pulmonary and Respiratory Medicine (248 citations) and Surgery (196 citations). Yuko Kitagawa has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Toshirou Nishida, Jean‐Yves Blay, Yoon‐Koo Kang, Seiichi Hirota, Akinori Watanabe, Kazumasa Fukuda, Ryo Yamaguchi, Masayuki Tanaka, Yoshihiro Kakeji and Yasunori Sato. Their work appears in journals such as Annals of Surgical Oncology, World Journal of Surgery and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.